97¹ú¼Ê

97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø
¼±Î£ÖØÖ¢Îü¸½½â¾ö¼Æ»®

ÖØÖ¢»¼Õß»úÌåÊܵ½Ñ¬È¾Ö®ºó£¬Ñ×ÐÔ·´Ó¦³Ê¼¶ÁªÊ½·Å´ó£¬¶øÈËÌåΪ¶Ô¿¹Ñ×Ö¢·´Ó¦¶øÐγɵĴú³¥ÐÔ·´Ó¦×ÛºÏÕ÷£¬Ò»µ©»¼Õß±¬·¢È«ÉíÐÔÑ×ÐÔ·´Ó¦Óë´ú³¥ÐÔ¿¹Ñ×·´Ó¦ÔÓÂÒ£¬¿ÉÒÔµ¼ÖÂÆäÌåÄÚµÄÇéÐÎÎÈ̬±»ÆÆË𣬷ºÆð×éÖ¯ËðÉË£¬×îÖÕ·ºÆð¶àÖÖÆ÷¹ÙµÄ¹¦Ð§Ë¥½ß[1]¡£97¹ú¼Ê¹«Ë¾Õë¶Ô²î±ðÀàÐÍÎ£ÖØÖ¢»¼ÕßÌṩÎü¸½½â¾ö¼Æ»®£¬97¹ú¼ÊHAÒ»´ÎÐÔѪҺ¹àÁ÷Æ÷£¬Ô­Ñо­µä£¬¹ãÆ×Îü¸½£¬ÓÐÓÃɨ³ýÒÔÑ×Ö¢½éÖÊΪ´ú±íµÄÖдó·Ö×Ó£¬¿ÉÓÃÓÚŧ¶¾Ö¢[2-3]¡¢ÖØÖ¢¼±ÐÔÒÈÏÙÑ×£¨SAP£©[4-5]¡¢¼±ÐÔºôÎüÞ×¾Ý×ÛºÏÕ÷£¨ARDS£©[6-7]µÈÑ×Ö¢Òò×ÓÏà¹ØÐÔ¼²²¡¼°ÐÄÍâ¿ÆÊÖÊõ»¼Õß[8]£»CA330ϸ°ûÒò×ÓÎü¸½Öù£¬ÖйúÊ׸ö»ñÅúÒ½ÁÆÆ÷еע²áÖ¤µÄϸ°ûÒò×ÓÎü¸½Àà²úÆ·£¬×¨ÓÃÓÚŧ¶¾Ö¢»¼ÕßÑ×Ö¢ÔçÆÚ»òϸ°ûÒò×ӷ籩ÆÚ¡£ÑªÒºÎü¸½Î£ÖØÖ¢ÁìÓòÖÎÁÆÄ£Ê½¶àÑù£¬ÁÙ´²ÉÏ¿ÉÒÔÆ¾Ö¤ÏÖÕæÏàÐε¥¶À¹àÁ÷ʹÓã¬Ò²¿ÉÓëÆäËûѪҺ¾»»¯Ä£Ê½ÍŽáʹÓã¬ÈçHP+HD/HDF/CVVH¡¢PFAD/CPFA[17]¡¢(PFAD-HD)/ CPFA-CRRT[17]¡¢HP+CPB¡¢HP+ECMO£¬¾ÙÐÐȫѪ»òÕßѪ½¬¹àÁ÷ÖÎÁÆ¡£

97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø
97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø
97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø
97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø
97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø
97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø

²Î¿¼ÎÄÏ×£º
[1]Sasaki S£¬Hasegawa T£¬Kawarazaki H£¬et al£® Development and validation of a clinical prediction rule for bacteremia among maintenance hemodialysis patients in outpatient setting£ÛJ£Ý£®PLoS One£¬2017£¬12( 1) : e0169975£®
[2]Zhao Huang, Si-rong Wang, Zi-li Yang, and Ji-yun Liu. Effect on Extrapulmonary Sepsis-Induced Acute Lung Injury by Hemoperfusion With Neutral Microporous Resin Column[J]. Therapeutic Apheresis and Dialysis, 2012:1-8.
[3]Huang Z, Wang SR, Su W, Liu JY. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial.2010 Dec;14(6):596-602.
[4]Sun, Shiren, et al. "High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study." Annals of Saudi medicine 35.5 (2015): 352-358.
[5]Tang Y, Zhang L, Fu P, et al. Hemoperfusion plus continuous veno-venous hemofiltration in a pregnant woman with severe acute pancreatitis: a case report.[J]. International Urology & Nephrology,2012, 44(3):987-990.
[6]Xu, Xuefeng, et al. "Effect of HA330resin-directed hemoadsorption on a porcine acute respiratory distress syndrome model." Annals of intensive care 7.1 (2017): 84.
[7]Li, Cong, Nana Xu, and Tie Xu. "Therapeutic Effects of Hemoperfusion Combined with High Volume Hemofiltration on Acute Respiratory Distress Syndrome Short Title: Treatment of ARDS." Revista Argentina de Clinica Psicológica 29.3(2020):311.
[8]Zijian He, etal. The Efficacy of Resin Hemoperfusion Cartridge on Inflammatory Responses during Adult Cardiopulmonary Bypass. Blood Purif.2021 Jun 9;1-7.
[9]ZHANG Lin,et al.Clinical study of mechanical ventilation combined with hemoperfusion and purification in the treatment of pneumothorax complicated by respiratory failure caused by traffic accident.Chin J Emerg Resusc Disaster Med.2021.
[10]Yuan,Hai,et al."Efficacy of two combinations of blood purification techniques for the treatment of multiple organ failure induced by wasp stings."Blood Purification 42.1 (2016):49-55.
[11]Zijian He,et al.The Efficacy of Resin Hemoperfusion Cartridge on Inflammatory Responses during Adult Cardiopulmonary Bypass.Blood Purif.2021 Jun 9;1-7.
[12]Xu,Xuefeng,et al."Effect of HA330 resin-directed hemoadsorption on a porcine acute respiratory distress syndrome model."Annals of intensive care 7.1 (2017):84.
[13]Li,Cong,Nana Xu,and Tie Xu."Therapeutic Effects of Hemoperfusion Combined with High Volume Hemofiltration on Acute Respiratory Distress Syndrome Short Title:Treatment ofARDS."Revista Argentina de Clinica Psicológica 29.3 (2020):311.
[14]Wang,Y.T.,et al."Effects of hemodialysis and hemoperfusion on inflammatory factors and nuclear transcription factors in peripheral blood cell of multiple organ dysfunction syndrome."Eur Rev Med Pharmacol Sci 20.4 (2016):745-50.
[15]Huang Bin,et al.Clinical study of continuous veno-venous hemofiltration combined with hemoperfusion in the treatment of severe burn sepsis.Journal of Clinicalemergency(China).2019:1009-5918.
[16]Prof.Claudio Ronco.CENTRO SPECIALIZZATO REGIONALE.PER LE TERAPIE DIALITICHE NELL'INSUFFICIENZA RENALE ACUTA E CRONICA E PER LE TECNOLOGIE EXTRACORPOREE di SUPPORTO MULTI-ORGANICO.2020.
[17]Ronco, C., & Bellomo, R. (2022). Hemoperfusion: technical aspects and state of the art. Critical care (London, England), 26(1), 135. https://doi.org/10.1186/s13054-022-04009-w.

ÁÙ´²Ó¦ÓÃ

97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø

¼±ÐÔÖж¾Îü¸½½â¾ö¼Æ»®

ѪҺ¹àÁ÷¿ÉÓÃÓÚÈËÌåÄÚÄÚÔ´ÐÔºÍÍâÔ´ÐÔ´úл²úÆ·¡¢¶¾Îï¼°ÓàÁ¿Ò©ÎïµÄɨ³ý,Òѱ»Ð´Èë¶àÏî¼±ÐÔÖж¾×¨¼Ò¹²Ê¶£¬Õë¶ÔÖÖÖÖ¼±ÐÔÖж¾»¼Õߣ¬HAÒ»´ÎÐÔѪҺ¹àÁ÷Æ÷£¬Ô­Ñо­µä£¬×ã³Ì¾»»¯£¬¿ÉÓÃÓÚÓлúũҩÖж¾[1-5]¡¢Ò©ÎïÖж¾[6-7]¡¢³ý²Ý¼ÁÖж¾[9-13]¡¢¶¾Þ¦Öж¾[14-16]¡¢·äÕÝÉË[17]µÈ¼±ÐÔÖж¾µÄÇÀ¾ÈÖÎÁÆ¡£ÁÙ´²ÉÏ¿ÉÒÔʹÓöàÀàѪҺ¾»»¯¶¯Á¦×°Öõ¥¶À¹àÁ÷ʹÓã¬Ò²¿ÉÓëÆäËûѪҺ¾»»¯Æ÷ÍŽáʹÓ㬾ÙÐÐȫѪ»òÕßѪ½¬¹àÁ÷ÖÎÁÆ¡£¿ÉÔÚ¹àÁ÷»ú(JF-800A),Future F20ѪҺ¾»»¯×°±¸¡¢Í¸Îö»ú¡¢CRRT»ú£¨Èç97¹ú¼ÊDX-10£©µÈ¶àÖÖѪҺ¾»»¯×°±¸ÉÏÍê³ÉÖÎÁÆ¡£

97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø
97¹ú¼Ê¡¤(ÖйúÇø)ÓÐÏÞ¹«Ë¾¹ÙÍø

²Î¿¼ÎÄÏ×£º
[1]ÑîÁ¢É½,¬ÖÐÇï,ÌïӢƽ,µÈ.¼±ÐÔÓлúÁ×ũҩÖж¾ÕïÖÎÁÙ´²×¨¼Ò¹²Ê¶(2016)[J].ÖйúÇÀ¾Èҽѧ,2016.
[2]ÕÅÃ÷ºÆ,ÕÅΰ,¼òΰÃ÷,µÈ.ѪҺ¹àÁ÷ÖÎÁƼ±ÐÔÖØ¶ÈÓлúÁ×ũҩÖж¾Çå¾²ÐÔºÍÓÐÓÃÐÔµÄMetaÆÊÎö[J].ҽѧ×ÛÊö,2020,26(14):8. [11]LI,Z.,WANG,G.,ZHEN,G.,etal.(2017).Applicationofhemoperfusioninsevereacuteorganophosphorus pesticidepoisoning.TURKISHJOURNALOFMEDICALSCIENCES,47,1277-1281.doi:10.3906/sag-1611-40.
[3]¶ÅÓî,IJÞÈ,ÕÔÁ¢Ç¿.ѪҺ¹àÁ÷ÖÎÁÆ´ÎÊý¶ÔÖØ¶È¼±ÐÔÓлúÁ×ũҩÖж¾ÁÆÐ§ºÍÔ¤ºóµÄÓ°Ïì[J].ÖйúÖÐÎ÷ҽ͎áÇÀ¾ÈÔÓÖ¾,2013,20(5):289-292.
[4]ÕÔºêÓî,º«Ð·É,ÕÔÃô,µÈ.ѪҺ¹àÁ÷ÖÎÁƼ±ÐÔÖØ¶ÈÓлúÁ×ũҩÖж¾µÄÆðʼʱ¼äÓëÁÆÐ§µÄÏà¹ØÐÔÑо¿[J].ÖйúÈ«¿ÆÒ½Ñ§,2011.14(14):1603-1604.1607.
[5]ÀîÓÂ,ÎâÕ÷ÕéÀîÁú¼±Õï´²ÅÔѪҺ¹àÁ÷ÖÎÁÆÍíÄêÕò¾²´ßÃßÀàÒ©ÎïÖж¾µÄÁÆÐ§[J].ÁÙ´²¼±ÕïÔÓÖ¾,2021,22(1):60-64.
[6]Îâ¸Õ,³ÂÕóÁõÒ×çåÔçÆÚ´²ÅÔѪҺ¹àÁ÷ÖÎÁƼ±ÐÔ¿¹Éñ¾­²¡Ò©ÎïÖж¾µÄÁÙ´²ÊÓ²ì[J].ÏÖ´úÒ½Ò©ÎÀÉú,2015,31(7):1042-1044.
[7]¹ùÀûÌÎ,ÁõêÅ,ÕÅÀÙ,ÍõÑ©,µÈ.ѪҺ¹àÁ÷¾ÈÖΰٲݿÝÖж¾ÒªÁì̽ÌÖ[J].ÖØÇìҽѧ,2013,42(5):552-553.
[8]Chen AB, Li F, Di EM, Zhang X, Zhao QY, Wen J. Influence of strengthened hemoperfusion combined with continuous venovenous hemofiltration on prognosis of patients with acute paraquat poisoning: SHP + CVVH improve prognosis of acute PQ patients. BMC Pharmacol Toxicol. 2020 Jul 6;21(1):49.
[9]ËïÁÁ,ÑàÅí²¨,Àî¹ú·å,µÈ.Ë«¹Þ´®ÁªÑª½¬¹àÁ÷¶ÔѪ½¬°Ù²Ý¿Ýɨ³ýЧ¹ûµÄÑо¿[J].ÖйúѪҺ¾»»¯,2013,12(3):149-151.
[10]ÖйúҽʦЭ»á¼±Õïҽʦ·Ö»á.¼±Ð԰ٲݿÝÖж¾ÕïÖÎר¼Ò¹²Ê¶(2013)[J].ÖйúÇÀ¾Èҽѧ,2013,33(6):6.
[11]°Ù²Ý¿ÝÖж¾Õï¶ÏÓëÖÎÁÆ'̩ɽ¹²Ê¶'ר¼Ò×é,ÝÑÏò¶«.°Ù²Ý¿ÝÖж¾Õï¶ÏÓëÖÎÁÆ"̩ɽ¹²Ê¶"(2014)[J].Öйú¹¤ÒµÒ½Ñ§ÔÓÖ¾,2014(2):117-119.
[12]ÕÔº½,ÕÔÃô,¼±ÐÔ¶¾Þ¦Öж¾µÄÁÙ´²ÆÊÎö[J].ÖйúÒ½¿Æ´óѧѧ±¨,2020,49(5):433-436.
[13]ÁÖ½àÓð,¶­Î°,ѪҺ¹àÁ÷ÍŽáѪҺÂ˹ýÓë´¿´âѪҺÂ˹ýÖÎÁÆÖØÖ¢¶¾Þ¦Öж¾Ð§¹û½ÏÁ¿[J].¹ãÖÝÒ½Ò©,2020,51(2):27-30.
[14]¶¡ÎÄ·É,Îâεèë,ÎÄÀò,µÈ,²î±ðѪҺ¾»»¯·½·¨ÖÎÁƶ¾Þ¦Öж¾µÄÁÙ´²ÊÓ²ì[J].¹ãÖÝÒ½Ò©,2020,51(2):27-30.
[15]ÖйúҽʦЭ»á¶ù¿ÆÒ½Ê¦·Ö»áѪҺ¾»»¯×¨ÒµÎ¯Ô±»á,¶ùͯѪҺ¹àÁ÷ÁÙ´²Ó¦ÓÃר¼Ò¹²Ê¶[J].ÖйúС¶ùÇÀ¾Èҽѧ,2018.25(8):8.
[16]Öйú¶¾Àíѧ»áÖж¾Óë¾ÈÖÎרҵίԱ»áÖлªÒ½Ñ§»áºþ±±Ê¡¼±Õïҽѧ·Ö»á,ºþ±±Ê¡Öж¾ÓëÖ°Òµ²¡Í¬ÃË.ºú·äó§É˹淶»¯ÕïÖÎÖйúר¼Ò¹²Ê¶[J].ÖлªÎ£Öز¡ÇÀ¾Èҽѧ,2018,30(9):5.
[17]³Ì»Ô,ÎÄÉêÓ¢,Áõ³¬.ѪҺ¹àÁ÷ÍŽáÒ»Á¬ÐÔÉöÔàÌæ»»ÖÎÁÆÔÚ·äòØÉËÖºáÎÆ¼¡ÏûÈںϲ¢¼±ÐÔÉöËðÉËÖеÄÓ¦ÓüÛÖµ[J].ÁÙ´²ºÍʵÑéҽѧÔÓÖ¾,2020,19(16):4.

Ïà¹Ø²úÆ·
TOP
΢ÐŶþάÂë ΢²©¶þάÂë
ÍøÕ¾µØÍ¼